巴基斯坦儿童广泛耐药结核病患者的治疗结果
Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan.
作者信息
Abubakar Muhammad, Ahmad Nafees, Atif Muhammad, Hayat Khan Amer, Ghafoor Abdul
机构信息
Dept of Pharmacy Practice, Faculty of Pharmacy and Health Sciences, University of Balochistan, Quetta, Pakistan.
Dept of Pharmacy Practice, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
出版信息
ERJ Open Res. 2022 Feb 21;8(1). doi: 10.1183/23120541.00551-2021. eCollection 2022 Jan.
相似文献
1
Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan.巴基斯坦儿童广泛耐药结核病患者的治疗结果
ERJ Open Res. 2022 Feb 21;8(1). doi: 10.1183/23120541.00551-2021. eCollection 2022 Jan.
2
A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country.在一个高耐药负担国家开展的关于耐多药和广泛耐药结核病知识与态度的横断面研究。
Int J Mycobacteriol. 2016 Jun;5(2):128-34. doi: 10.1016/j.ijmyco.2015.12.004. Epub 2016 Feb 18.
3
Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.来自巴基斯坦的广泛耐药结核分枝杆菌分离株中外排泵基因的单核苷酸多态性
Tuberculosis (Edinb). 2017 Dec;107:20-30. doi: 10.1016/j.tube.2017.07.012. Epub 2017 Aug 3.
4
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.广泛耐药和预广泛耐药结核分枝杆菌对左氧氟沙星、利奈唑胺和阿莫西林克拉维酸的药敏试验。
Antimicrob Agents Chemother. 2013 Jun;57(6):2522-5. doi: 10.1128/AAC.02020-12. Epub 2013 Mar 18.
5
Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.中国国家结核病临床中心广泛耐药结核病及附加耐药的流行状况和治疗结局：一项为期五年的回顾性研究。
J Infect. 2017 Nov;75(5):433-440. doi: 10.1016/j.jinf.2017.08.005. Epub 2017 Aug 11.
6
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
7
Extensively Drug-Resistant Tuberculosis in the Time of COVID-19-How has the Landscape Changed for Pakistan?新冠疫情下的广泛耐药结核病——巴基斯坦的情况发生了怎样的变化？
Disaster Med Public Health Prep. 2020 Aug;14(4):e9-e10. doi: 10.1017/dmp.2020.230. Epub 2020 Jul 7.
8
Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.巴西圣保罗耐多药结核病患者中广泛耐药结核病的流行情况、相关因素、结局和传播：一项横断面研究。
Clin Microbiol Infect. 2018 Aug;24(8):889-895. doi: 10.1016/j.cmi.2017.11.015. Epub 2017 Nov 22.
9
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.埃塞俄比亚阿姆哈拉地区耐多药结核病患者中广泛耐药前和广泛耐药结核病的负担。
PLoS One. 2020 Feb 13;15(2):e0229040. doi: 10.1371/journal.pone.0229040. eCollection 2020.
10
Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.基于耐药模式的耐多药结核病的治疗结果和生存情况。
Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.
引用本文的文献
1
Development and validation of a nomogram predicting multidrug-resistant tuberculosis risk in East China.华东地区预测耐多药结核病风险的列线图的开发与验证
PeerJ. 2025 Feb 27;13:e19112. doi: 10.7717/peerj.19112. eCollection 2025.
2
Treatment outcomes among children and adolescents with extensively drug-resistant (XDR) and pre-XDR tuberculosis: Systematic review and meta-analysis.广泛耐药和准广泛耐药结核病儿童及青少年的治疗结局：系统评价与荟萃分析
PLOS Glob Public Health. 2025 Jan 29;5(1):e0003754. doi: 10.1371/journal.pgph.0003754. eCollection 2025.
3
Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.为什么耐多药结核病患者不完成治疗？来自巴基斯坦的定性研究结果。
BMJ Open Respir Res. 2024 Feb 26;11(1):e002186. doi: 10.1136/bmjresp-2023-002186.
4
Drug-Resistant Tuberculosis Treatment Outcomes among Children and Adolescents in Karachi, Pakistan.巴基斯坦卡拉奇儿童和青少年耐多药结核病的治疗结果
Trop Med Infect Dis. 2022 Dec 6;7(12):418. doi: 10.3390/tropicalmed7120418.
本文引用的文献
1
Treatment Outcomes of Extensively Drug-Resistant Tuberculosis in Pakistan: A Countrywide Retrospective Record Review.巴基斯坦广泛耐药结核病的治疗结果：一项全国性回顾性记录审查
Front Pharmacol. 2021 Mar 31;12:640555. doi: 10.3389/fphar.2021.640555. eCollection 2021.
2
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.贝达喹啉和德拉马尼联合治疗耐多药或耐药患者的治疗结果：来自一个大型全球队列的结果。
Pulmonology. 2021 Sep-Oct;27(5):403-412. doi: 10.1016/j.pulmoe.2021.02.006. Epub 2021 Mar 19.
3
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.巴基斯坦耐多药结核病患者更短治疗方案的疗效：一项多中心回顾性病历研究。
Am J Trop Med Hyg. 2021 Mar 15;104(5):1784-1791. doi: 10.4269/ajtmh.20-1134.
4
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19.在白俄罗斯，2015-2019 年间，含德拉马尼或贝达喹啉方案治疗儿童和青少年耐多药或广泛耐药结核病的疗效和安全性：一项全国性研究。
Monaldi Arch Chest Dis. 2021 Jan 14;91(1). doi: 10.4081/monaldi.2021.1646.
5
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.全球系统评价和儿童耐多药结核病患者荟萃分析的治疗结果。
Emerg Infect Dis. 2019 Mar;25(3):441-450. doi: 10.3201/eid2503.180852.
6
Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.时间至痰培养转阴预测耐多药结核病患者治愈的有效性：一项回顾性单中心研究。
Am J Trop Med Hyg. 2018 Jun;98(6):1629-1636. doi: 10.4269/ajtmh.17-0936. Epub 2018 Mar 29.
7
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.含贝达喹啉方案治疗耐多药和广泛耐药结核病的疗效和安全性：一项多中心研究。
Eur Respir J. 2017 May 21;49(5). doi: 10.1183/13993003.00387-2017. Print 2017 May.
8
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.南非广泛耐药结核病的传播
N Engl J Med. 2017 Jan 19;376(3):243-253. doi: 10.1056/NEJMoa1604544.
9
Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.耐多药结核病的管理与治疗结果：来自耐药率高的地区的结果
Int J Tuberc Lung Dis. 2015 Sep;19(9):1109-14, i-ii. doi: 10.5588/ijtld.15.0167.
10
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city.耐多药和广泛耐药结核病在一个大都市的传播。
Eur Respir J. 2013 Apr;41(4):901-8. doi: 10.1183/09031936.00071212. Epub 2012 Aug 9.
Zotero 插件